{"id":"W2791438625","doi":"10.1007/s11864-018-0532-2","title":"When to Stop Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia","year":2018,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Nilotinib; Chronic myelogenous leukemia; Dasatinib; Oncology; Internal medicine; Tyrosine-kinase inhibitor; Imatinib mesylate; Myeloid leukemia; Clinical trial; Clinical endpoint; Intensive care medicine; Imatinib; Leukemia; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002631742,0.001208549,0.003751057,0.0008649413,0.0002209198,0.00002344234,0.0003738789,0.000641085,0.0002602318],"category_scores_gemma":[0.0001117969,0.0007258233,0.00150988,0.0007386094,0.0003967939,0.00005918293,0.0001030074,0.0002861624,0.0002998145],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.07760677,"about_ca_system_score_gemma":0.008900765,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002424385,"about_ca_topic_score_gemma":0.0006048897,"domain_scores_codex":[0.9955264,0.0002780403,0.001699202,0.001245489,0.000320544,0.0009303471],"domain_scores_gemma":[0.9956964,0.001392586,0.0006947778,0.001666653,0.0002077091,0.0003419004],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002040189,0.006122129,0.00003129076,0.002761234,0.001340722,0.00004196533,0.0006709014,0.00002705233,0.000002599991,0.0001656763,0.004301387,0.984331],"study_design_scores_gemma":[0.009627361,0.02203962,0.00003083446,0.006626068,0.007338537,0.0001181098,0.0000543158,0.00008272471,0.00003875759,0.0000264834,0.9535869,0.000430325],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006220334,0.9816106,0.0001092069,0.0003615549,0.002972287,0.01334331,0.0006917546,0.00008228483,0.0002069964],"genre_scores_gemma":[0.00007194663,0.9779155,0.001542186,0.00001795192,0.002085069,0.01438591,0.00162577,0.000149128,0.002206523],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9839007,"threshold_uncertainty_score":0.9995193,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1071103467826513,"score_gpt":0.4213271519235706,"score_spread":0.3142168051409193,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}